Early Phase 1 Pancreatic Cancer Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People aged between 18 and 75 years old (inclusive), of any gender.
• People who have been diagnosed with a specific type of pancreatic cancer (pancreatic ductal adenocarcinoma or IPMN carcinosis) confirmed by laboratory testing of tissue or cells, and whose cancer has not responded to at least one previous systemic treatment.
• People whose general physical functioning falls within an acceptable range on a standard medical performance scale (confirm with trial site).
• People whose doctor judges them to have a life expectancy of at least 3 months at the time of screening.
• People who have at least one measurable area of cancer that can be tracked using standard imaging criteria.
• People whose organs and bone marrow are functioning adequately, as shown by laboratory tests within acceptable ranges (note: drainage procedures for bile duct blockage caused by pancreatic cancer are permitted).
• People whose side effects from previous cancer treatments have settled to a mild or absent level before joining.
• People who are not pregnant, and if capable of becoming pregnant, those who are willing to use effective contraception from the time of signing consent until 6 months after the last treatment infusion.
• People who are willing and able to sign a written consent form agreeing to participate.
• People who are able and willing to follow the study's treatment schedule, attend required tests, and complete follow-up visits.

Who may not be able to join:

• People who are pregnant or currently breastfeeding.
• People who test positive for HIV, syphilis, or Hepatitis C (though people with Hepatitis C antibodies but no active virus, stable syphilis, or inactive infection may still be considered — confirm with trial site).
• People who have any active infection, including active tuberculosis, active Hepatitis B, active Epstein-Barr virus, active cytomegalovirus, active COVID-19, or any other bacterial, viral, or fungal infection currently requiring medication.
• People who have been diagnosed with another cancer within the past 5 years (exceptions may apply for certain non-invasive skin cancers or cervical changes — confirm with trial site).
• People who have any other health condition that the trial doctor judges would make participation unsafe or unsuitable.

Important: Always verify eligibility with the trial site directly before applying.